加强多学科协作,努力提高肢端肥大症诊治水平——《中国肢端肥大症诊治指南(2013版)》解读  

Intensive Multidiscipline Co-operation,Enhanced Diagnosis and Management of Acromegaly——Interpretation of "Chinese Guideline of Treatment and Management of Acromegaly,2013"

作　　者：雷霆[1] 徐钰[1] 陈娟[1] 

机构地区：[1]华中科技大学同济医学院附属同济医院神经外科,湖北武汉430030

出　　处：《中国神经肿瘤杂志》2013年第4期226-229,共4页Chinese Journal of Neuro-Oncology

基　　金：卫生部临床重点专科建设项目基金资助

摘　　要：由中华医学会内分泌学分会和神经外科学分会、中国垂体瘤协作组共同组织全国众多专家修订的《中国肢端肥大症诊治指南(2013版)》公开发表。本次对指南有较多关键修改之处,主要表现在几个方面:促进多学科交叉,早期诊断和治疗;影响手术治疗效果的主要因素;药物及其他治疗;深入探讨垂体生长激素腺瘤发病机制的重要性。Lately, ＂Chinese guideline of treatment and management of acromegaly, 2013＂ was revised and published jointly by Chinese Society of Endocrinology, Chinese Society of Neurosurgery and Chinese Pituitary Adenoma Cooperative Group. This guideline has improved in several aspects as following： 1） Strengthened muhidiscipline cooperation leads to early diagnosis and treatment of acromegaly; 2） Major factors influencing the post- operative effect; 3） Medication and other treatments; 4） The significance of pathogenesis of Growth-hormone secreting pituitary adenomas.

关 键 词：肢端肥大症 指南 解读 

分 类 号：R739.41[医药卫生—肿瘤]